Roberta Casalini
Via Paradisa 2
Pisa, 56124, Italy
Pisa, 56124, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Impairment in the hypothalamic-pituitary-gonadal axis in males with medullary thyroid carcinoma treated with selpercatinib.
Journal: The Journal of clinical endocrinology and metabolism
Published: April 03, 2026
Liquid Biopsy-Based RET Mutation Profiling to Guide RET Inhibitor Treatment in Sporadic Medullary Thyroid Carcinoma May Be Useful in Cases with High Tumor Burden and Progressive Disease.
Journal: Thyroid : official journal of the American Thyroid Association
Published: January 24, 2026
Calcitonin thresholds for prediction of medullary thyroid carcinoma and its clinical response in MEN2A gene carriers.
Journal: The Journal of clinical endocrinology and metabolism
Published: October 21, 2025
Molecular Profile of Advanced Radioiodine-refractory Thyroid Cancer and Response to Lenvatinib Treatment.
Journal: The Journal of clinical endocrinology and metabolism
Published: October 14, 2025
Redefining the prevalence of different clinical variants in MEN2A and their correlation with RET germline mutations: a single-center series and experience.
Journal: Endocrine-related cancer
Published: July 04, 2025
Genetic origin of multifocal sporadic medullary thyroid cancer and C-cell hyperplasia.
Journal: European journal of endocrinology
Published: February 12, 2025
Prevalence and genetics of "de novo" MEN2 syndromes.
Journal: The Journal of clinical endocrinology and metabolism
Published: January 09, 2025
Minor role of TP53 and TERT promoter mutations in medullary thyroid carcinoma: report of new cases and revision of the literature.
Journal: Endocrine
Published: July 03, 2024
NF1 Gene Inactivation Acts as Tumor Driver in RET/RAS Negative Medullary Thyroid Carcinomas.
Journal: European journal of endocrinology
Published: January 27, 2023
Chromosomal alterations in sporadic medullary thyroid carcinoma and correlation with outcome.
Journal: Endocrine-related cancer
Published: August 23, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026